Edwin has spent over 20 years bringing new life science technologies to market, the last 10 of these focused on solving the challenges of cell therapy manufacturing. He established TTP’s cell and gene team which developed over 10 cell therapy automation systems, including systems that are now in routine use for commercial therapy manufacture. Seeing the challenge of scale remained unaddressed, Edwin co-founded Cellular Origins where he is passionate about enabling patient access to cell therapies through scalable, cost-effective and space efficient manufacturing enabled by the Constellation™ automated cell therapy manufacturing platform. He holds a Master’s degree in Engineering and a PhD in robotic vehicles from the University of Cambridge.

Meg Wood is Managing Director of NYBC Ventures, where she leverages her expertise in venture capital and strategic investments to identify and support innovative companies. With a strong background in investing and a passion for emerging technologies, Meg plays an integral role in driving the firm’s investment strategy, fostering growth and value creation across the portfolio. She earned her master’s degree from Boston University’s School of Public Health, where she developed a deep understanding of finance and entrepreneurship. Meg is committed to advancing NYBC Ventures’ mission of shaping the future of industries through transformative investing.